Fiche centre
IRCCS National Neurological Institute "C. Mondino" Foundation
Pavia — Italy
Essais liés3clinical trials
VillePavialocalisation
PaysItalylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05903040
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Rimegepant 75 MG Disintegrating Oral Tablet | Migraine | À vérifier | NCT05903027 | Gepant treAtments: EffectIveNess and tolERability (GAINER) | RECRUITING |
| Rimegepant 75 MG | Migraine | À vérifier | NCT06409832 | RAISE — RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment | RECRUITING |
| Lasmiditan | Migraine | À vérifier | NCT05903040 | Ditan Acute tReatments: Effectiveness and Tolerability (DART) | COMPLETED |